Limitations, agreements, and source contact

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer · Source last updated 2019-08-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

limitations And Caveats

description

This study did not meet the anticipated accrual goal of 24 participants.

point Of Contact

email

jingsong.zhang@moffitt.org

organization

H. Lee Moffitt Cancer Center and Research Institute

phone

813-745-3973

title

Dr. Jingsong Zhang

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice